Research 2003: Spirit of Inquiry
 MU Office of Research Home page. Year In Review. Technology Development. Sponsored Research. Instruction & Public Service. 2003 & Beyond.

Annual Report 2003 Query Tool

Investigators Reach New High in Research Expenditures

Cancer Imaging With Radiopharmaceuticals

Arthritis Rehabilitation Research and Training

A Home for Swine Studies

Rethinking Mathematics Instruction

Seeking Answers to Coronary Artery Disease

Director Named for LSC

Maize Genome Mapping Project Nears Completion

Cancer Imaging with Radiopharmaceuticals

The National Cancer Institute (NCI), an agency within the federal National Institutes of Health, in July awarded MU a $10 million grant to create a new Center for Single Photon-Emitting Cancer Imaging Agents.

The award is one of the largest research grants ever received by MU through a peer-reviewed, competitive government funding process. It will allow researchers at MU and the Harry S Truman Memorial Veterans Hospital to pioneer new, innovative methods of cancer detection and treatment.

The grant strengthens a formal agreement between MU and the Truman Memorial Veterans Administration Hospital to build a premiere cancer-imaging center. The center will be housed in the 9,000-square-foot radiopharmaceuticals laboratory located on the lowest level of the new outpatient center at the hospital.
Wynn Volkert, professor of radiology and leader of the project, said the recent development of the radiopharmaceuticals lab, made possible by a $4 million federal appropriation procured by U.S. Senator Christopher "Kit" Bond, was one reason the NCI chose MU rather than Stanford University or Duke University for the center.

"I am very pleased that the initial $4 million investment that I secured allowed MU to win this $10 million cancer research contract," said Sen. Bond. "This announcement underscores that MU is increasingly capable of competing for and winning front-line, big-dollar research contracts."

Radiopharmaceuticals are radioactive drugs that help doctors detect, diagnose and treat diseases. Doctors inject molecules "labeled" with radioisotopes into patients, where the molecular structure of the drug allows it to "target" specific tissues. Once the radioactive material reaches its target -- whether the heart, liver, brain or a tumor -- specialized instruments are used to produce an image that helps physicians make more informed diagnoses.

University of Missouri-Columbia
Columbia, MO 65211
Phone: (573) 882-2121

Copyright © 2004 Curators of the University of Missouri
DMCA and other copyright information
An equal opportunity/ADA institution




University of Missouri - Columbia Home page. University of Missouri - Columbia Home page. MU Office of Research Home page.